MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$21,876K
EPS
-$1.52
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
12,473
9,334
5,178*
6,528
General and administrative
8,932
5,521
4,090*
3,649
Total operating expenses
21,405
14,855
9,267
10,177
Operating loss
-21,405
-14,855
-9,267*
-10,177
Interest expense - royalty agreement
-2,308
-2,039
-1,522*
-1,510
Interest expense - convertible notes payable
-
-
0*
0
Fair value adjustments on derivative liabilities - royalty agreement
-114
-116
-94*
-82
Fair value adjustments on convertible notes payable
-
-
0*
0
Fair value adjustments on derivative liabilities - contingent value right liability
0
202
-54*
-
Fair value adjustments on derivative liabilities - contingent value right agreement
-
-
-
-238
Other income - german r&d tax credit receivable
-
-
0*
-
Interest income, net
1,965
1,073
613*
628
Other (expense) income, net
-8
-32
-165*
34
Loss before income taxes
-21,870
-15,767
-10,490*
-11,345
Income tax benefit (expense)
0
0
0*
0
Net loss
-21,870
-15,767
-10,490*
-11,345
Less cumulative series d preferred dividends
-
-
-
0
Loss attributable to common stockholders
-
-
-
-11,345
Unrealized loss on investments
-30
4
-
-
Foreign currency translation loss (gain)
24
8
-80*
215
Comprehensive loss
-21,876
-15,755
-10,571
-11,130
Basic EPS
-1.52
-1.2
-0.908
-1.03
Diluted EPS
-1.52
-1.2
-0.908
-1.03
Basic Average Shares
14,356,219
13,085,271
11,636,727
11,064,282
Diluted Average Shares
14,356,219
13,085,271
11,636,727
11,064,282
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$21,876K
(-128.37%↓ Y/Y)
Foreign currency
translation loss (gain)
$24K
(122.22%↑ Y/Y)
Net loss
-$21,870K
(-130.92%↓ Y/Y)
Unrealized loss on
investments
-$30K
Loss before income
taxes
-$21,870K
(-130.92%↓ Y/Y)
Interest income, net
$1,965K
(184.78%↑ Y/Y)
Operating loss
-$21,405K
(-131.41%↓ Y/Y)
Interest expense -
royalty agreement
-$2,308K
(-70.46%↓ Y/Y)
Fair value
adjustments on derivative...
-$114K
(3.39%↑ Y/Y)
Other (expense)
income, net
-$8K
(-101.43%↓ Y/Y)
Total operating
expenses
$21,405K
(131.41%↑ Y/Y)
Research and development
$12,473K
(143.71%↑ Y/Y)
General and
administrative
$8,932K
(116.17%↑ Y/Y)
Buy us a coffee
PALVELLA THERAPEUTICS, INC. (PVLA)
PALVELLA THERAPEUTICS, INC. (PVLA)